Charles River Laboratories International (NYSE:CRL) Posts Quarterly Earnings Results, Beats Estimates By $0.07 EPS

Charles River Laboratories International (NYSE:CRL – Get Free Report) announced its earnings results on Wednesday. The medical research company reported $2.46 earnings per share for the quarter, topping the consensus estimate of $2.39 by $0.07, Briefing.com reports. Charles River Laboratories International had a net margin of 11.27% and a return on equity of 18.15%. The […]

Related Keywords

United States ,Canada ,Robertw Baird ,Birgit Girshick ,Asia Pacific ,Research Models ,Charles River Laboratories International Inc ,Gotham Asset Management ,Securities Exchange Commission ,Profund Advisors ,Healthcare Of Ontario Pension Plan Trust Fund ,Morgan Stanley ,Charles River Laboratories International ,Citigroup ,Earnings History For Charles River Laboratories International ,Charles River Laboratories International Price Performance ,Prelude Capital Management ,Manufacturing Solutions ,Get Free Report ,River Laboratories International ,Exchange Commission ,Capital Management ,Asset Managment ,Asset Management ,Ontario Pension Plan Trust Fund ,Safety Assessment ,Charles River Laboratories International Daily ,Nyse Crl ,Crl ,Medical ,15986410 ,Earnings ,